Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Q/C Technologies, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +4 vs. Q1 2026
- Shares held
- 736.8K
- +110.9K (+17.7%) vs. Q1 2026
- Total value
- $2.87M
- +$714.6K (+33.1%) vs. Q1 2026
- New holders
- 6
- 5 more added
- Sold out
- 2
- 4 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QCLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.87M |
| Q1 2026 | 18 | $2.16M |
| Q4 2025 | 19 | $3.00M |
| Q3 2025 | 11 | $69.8K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Q/C Technologies, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quinn Opportunity Partners LLC | 123,024 | $479.8K | 0.02% | −88,366−41.8% | Reduced |
| Vanguard Capital Management LLC | 115,031 | $448.6K | 0.00% | +77,520+206.7% | Added |
| Jane Street Group, LLC | 87,241 | $340.2K | 0.00% | −38,947−30.9% | Reduced |
| Geode Capital Management, LLC | 70,682 | $275.7K | 0.00% | +23,292+49.1% | Added |
| UBS Group AG | 58,894 | $229.7K | 0.00% | −19,095−24.5% | Reduced |
| Balyasny Asset Management LLC | 57,692 | $225.0K | 0.00% | +57,692 | New |
| HRT Financial LP | 50,373 | $196.0K | 0.00% | +27,969+124.8% | Added |
| ADAR1 Capital Management, LLC | 50,000 | $195.0K | 0.01% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 43,053 | $167.9K | 0.00% | +27,498+176.8% | Added |
| State Street Corp | 25,305 | $98.7K | 0.00% | +12,400+96.1% | Added |
| Dimensional Fund Advisors LP | 19,058 | $74.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,997 | $70.2K | 0.00% | +17,997 | New |
| PEAK6 LLC | 12,778 | $49.8K | 0.00% | +12,778 | New |
| Pin Oak Investment Advisors Inc | 3,500 | $14.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,043 | $4.07K | 0.00% | −550−34.5% | Reduced |
| Barclays PLC | 950 | $3.71K | 0.00% | +950 | New |
| SBI Securities Co., Ltd. | 100 | $390 | 0.00% | +100 | New |
| BlackRock, Inc. | 19 | $74 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 9 | $35 | 0.00% | +9 | New |
| Jones Financial Companies LLLP | 2 | $7 | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 1 | $4 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |